chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Nausea, Pyrexia
Clinical narrative: like flu symptoms; feeling unwell; has no energy; has no appetite; Can't do anything; felt like had fever but don't; tired and exhausted; little nauseous; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (like flu symptoms), MALAISE (feeling unwell), ASTHENIA (has no energy), DECREASED APPETITE (has no appetite) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Can't do anything) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (like flu symptoms), MALAISE (feeling unwell), ASTHENIA (has no energy), DECREASED APPETITE (has no appetite), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Can't do anything), PYREXIA (felt like had fever but don't), FATIGUE (tired and exhausted) and NAUSEA (little nauseous). At the time of the report, INFLUENZA LIKE ILLNESS (like flu symptoms), MALAISE (feeling unwell), ASTHENIA (has no energy), DECREASED APPETITE (has no appetite), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Can't do anything), PYREXIA (felt like had fever but don't), FATIGUE (tired and exhausted) and NAUSEA (little nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea, Discomfort, Nausea, Nervousness
Clinical narrative: Weak; Tingling; Chin and Neck feel funny; Shaky; Body Feels like Collapsing; Nauseas; Vomited; Diarrahea; Ached; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS (Shaky), DIARRHOEA (Diarrahea), ASTHENIA (Weak), PARAESTHESIA (Tingling) and DISCOMFORT (Chin and Neck feel funny) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included PREDNISONE for an unknown indication.    On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 08-Mar-2021, the patient experienced DIARRHOEA (Diarrahea), PAIN (Ached), NAUSEA (Nauseas) and VOMITING (Vomited). On 12-Mar-2021, the patient experienced NERVOUSNESS (Shaky), ASTHENIA (Weak), PARAESTHESIA (Tingling), DISCOMFORT (Chin and Neck feel funny) and PAIN (Body Feels like Collapsing). At the time of the report, NERVOUSNESS (Shaky), DIARRHOEA (Diarrahea), ASTHENIA (Weak), PARAESTHESIA (Tingling), DISCOMFORT (Chin and Neck feel funny), PAIN (Ached), PAIN (Body Feels like Collapsing), NAUSEA (Nauseas) and VOMITING (Vomited) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient had her adrenal glands removed.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Paraesthesia, Vomiting
Clinical narrative: Weak; Tingling; Chin and Neck feel funny; Shaky; Body Feels like Collapsing; Nauseas; Vomited; Diarrahea; Ached; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS (Shaky), DIARRHOEA (Diarrahea), ASTHENIA (Weak), PARAESTHESIA (Tingling) and DISCOMFORT (Chin and Neck feel funny) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included PREDNISONE for an unknown indication.    On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 08-Mar-2021, the patient experienced DIARRHOEA (Diarrahea), PAIN (Ached), NAUSEA (Nauseas) and VOMITING (Vomited). On 12-Mar-2021, the patient experienced NERVOUSNESS (Shaky), ASTHENIA (Weak), PARAESTHESIA (Tingling), DISCOMFORT (Chin and Neck feel funny) and PAIN (Body Feels like Collapsing). At the time of the report, NERVOUSNESS (Shaky), DIARRHOEA (Diarrahea), ASTHENIA (Weak), PARAESTHESIA (Tingling), DISCOMFORT (Chin and Neck feel funny), PAIN (Ached), PAIN (Body Feels like Collapsing), NAUSEA (Nauseas) and VOMITING (Vomited) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient had her adrenal glands removed.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Dysstasia, Gait disturbance, Intervertebral disc protrusion
Clinical narrative: Herniated lumbar disc; Back pain; Difficult standing; Difficult walking; A spontaneous report was received from a consumer concerning a 50-years-old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced back pain, difficult standing/ dysstasia, walking/ gait disturbance and herniated lumbar disc/ intervertebral disc protrusion.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On 19 Feb 2021, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number: 023M20A) via unknown route in the right arm for prophylaxis of COVID-19 infection. On 01 Mar 2021, prior to the onset of the symptoms, the patient received their second of two planned doses of mRNA-1273 (Batch number not provided) via unknown route in the right arm for prophylaxis of COVID-19 infection.  On 1 Mar 2021, the patient experienced back pain, difficult standing, walking and was diagnosed herniated lumbar disc.  Treatment information was not provided.  The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event is not applicable.   The outcome of events, back pain, difficult standing, walking and was diagnosed herniated lumbar disc was not reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: extremely tired/fatigue was the worst; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (extremely tired/fatigue was the worst) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced FATIGUE (extremely tired/fatigue was the worst). On 12-Mar-2021, FATIGUE (extremely tired/fatigue was the worst) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: started being itchy all over and itching like crazy; This spontaneous case was reported by a health care professional and describes the occurrence of PRURITUS (started being itchy all over and itching like crazy) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     Concurrent medical conditions included Arrhythmia, Anxiety, Acid reflux (esophageal) and Allergy to antibiotic (Patient is allergic to Antibiotics.).    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced PRURITUS (started being itchy all over and itching like crazy). On 13-Feb-2021, PRURITUS (started being itchy all over and itching like crazy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication provided. No concomitant medication provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Injection site erythema, Injection site pruritus, Injection site swelling, Limb discomfort
Clinical narrative: Injection site swelling; Arm was red; Itching in the arm; sore; Discomfort; Arm Discomfort; Pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (Discomfort), LIMB DISCOMFORT (Arm Discomfort), PAIN IN EXTREMITY (Pain in arm), INJECTION SITE PRURITUS (Itching in the arm) and PAIN (sore) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Medical history was not provided by the reporter.  Concomitant products included LISINOPRIL, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and MULTIVITAMIN & MINERAL for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced DISCOMFORT (Discomfort), LIMB DISCOMFORT (Arm Discomfort), PAIN IN EXTREMITY (Pain in arm) and PAIN (sore). On 08-Mar-2021, the patient experienced INJECTION SITE PRURITUS (Itching in the arm). On 09-Mar-2021, the patient experienced INJECTION SITE ERYTHEMA (Arm was red). On 10-Mar-2021, the patient experienced INJECTION SITE SWELLING (Injection site swelling). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, DISCOMFORT (Discomfort), LIMB DISCOMFORT (Arm Discomfort), PAIN IN EXTREMITY (Pain in arm), INJECTION SITE PRURITUS (Itching in the arm), PAIN (sore), INJECTION SITE ERYTHEMA (Arm was red) and INJECTION SITE SWELLING (Injection site swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment includes ice.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: Injection site swelling; Arm was red; Itching in the arm; sore; Discomfort; Arm Discomfort; Pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (Discomfort), LIMB DISCOMFORT (Arm Discomfort), PAIN IN EXTREMITY (Pain in arm), INJECTION SITE PRURITUS (Itching in the arm) and PAIN (sore) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Medical history was not provided by the reporter.  Concomitant products included LISINOPRIL, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and MULTIVITAMIN & MINERAL for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced DISCOMFORT (Discomfort), LIMB DISCOMFORT (Arm Discomfort), PAIN IN EXTREMITY (Pain in arm) and PAIN (sore). On 08-Mar-2021, the patient experienced INJECTION SITE PRURITUS (Itching in the arm). On 09-Mar-2021, the patient experienced INJECTION SITE ERYTHEMA (Arm was red). On 10-Mar-2021, the patient experienced INJECTION SITE SWELLING (Injection site swelling). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, DISCOMFORT (Discomfort), LIMB DISCOMFORT (Arm Discomfort), PAIN IN EXTREMITY (Pain in arm), INJECTION SITE PRURITUS (Itching in the arm), PAIN (sore), INJECTION SITE ERYTHEMA (Arm was red) and INJECTION SITE SWELLING (Injection site swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment includes ice.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pyrexia
Clinical narrative: Fever / temperature was 100.0°F; nauseated; just a head ache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever / temperature was 100.0°F), HEADACHE (just a head ache) and NAUSEA (nauseated) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced HEADACHE (just a head ache). On 12-Mar-2021, the patient experienced PYREXIA (Fever / temperature was 100.0°F) and NAUSEA (nauseated). At the time of the report, PYREXIA (Fever / temperature was 100.0°F), HEADACHE (just a head ache) and NAUSEA (nauseated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was not provided by the reporter.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Headache, Paraesthesia oral
Clinical narrative: Patient started feeling metallic taste; Tingling on her tongue; Patient has a slight headache; This spontaneous case was reported by a patient and describes the occurrence of DYSGEUSIA (Patient started feeling metallic taste), PARAESTHESIA ORAL (Tingling on her tongue) and HEADACHE (Patient has a slight headache) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     Concomitant products included TICAGRELOR (BRILINTA), VITAMIN D NOS and VITAMIN B COMPLEX for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 12-Mar-2021, the patient experienced DYSGEUSIA (Patient started feeling metallic taste), PARAESTHESIA ORAL (Tingling on her tongue) and HEADACHE (Patient has a slight headache). At the time of the report, DYSGEUSIA (Patient started feeling metallic taste), PARAESTHESIA ORAL (Tingling on her tongue) and HEADACHE (Patient has a slight headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications also included unspecified thyroid and pain medication.  Treatment information was not provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: L arm soreness; muscle ache at site of injection; itchy like hives; itchy and red L arm at site of injection; Red; L arm, site of injection with a bruise; L arm, site of injection swollen; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (L arm, site of injection with a bruise), URTICARIA (itchy like hives), INJECTION SITE PRURITUS (itchy and red L arm at site of injection), MYALGIA (L arm soreness) and INJECTION SITE PAIN (muscle ache at site of injection) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported by the reporter.  Concomitant products included VITAMINS NOS and THYROID for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced CONTUSION (L arm, site of injection with a bruise) and INJECTION SITE SWELLING (L arm, site of injection swollen). On 11-Mar-2021, the patient experienced INJECTION SITE PRURITUS (itchy and red L arm at site of injection) and INJECTION SITE ERYTHEMA (Red). On 12-Mar-2021, the patient experienced URTICARIA (itchy like hives). On an unknown date, the patient experienced MYALGIA (L arm soreness) and INJECTION SITE PAIN (muscle ache at site of injection). At the time of the report, CONTUSION (L arm, site of injection with a bruise), URTICARIA (itchy like hives), INJECTION SITE PRURITUS (itchy and red L arm at site of injection), MYALGIA (L arm soreness), INJECTION SITE PAIN (muscle ache at site of injection), INJECTION SITE SWELLING (L arm, site of injection swollen) and INJECTION SITE ERYTHEMA (Red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication was not provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Urticaria
Clinical narrative: L arm soreness; muscle ache at site of injection; itchy like hives; itchy and red L arm at site of injection; Red; L arm, site of injection with a bruise; L arm, site of injection swollen; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (L arm, site of injection with a bruise), URTICARIA (itchy like hives), INJECTION SITE PRURITUS (itchy and red L arm at site of injection), MYALGIA (L arm soreness) and INJECTION SITE PAIN (muscle ache at site of injection) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported by the reporter.  Concomitant products included VITAMINS NOS and THYROID for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced CONTUSION (L arm, site of injection with a bruise) and INJECTION SITE SWELLING (L arm, site of injection swollen). On 11-Mar-2021, the patient experienced INJECTION SITE PRURITUS (itchy and red L arm at site of injection) and INJECTION SITE ERYTHEMA (Red). On 12-Mar-2021, the patient experienced URTICARIA (itchy like hives). On an unknown date, the patient experienced MYALGIA (L arm soreness) and INJECTION SITE PAIN (muscle ache at site of injection). At the time of the report, CONTUSION (L arm, site of injection with a bruise), URTICARIA (itchy like hives), INJECTION SITE PRURITUS (itchy and red L arm at site of injection), MYALGIA (L arm soreness), INJECTION SITE PAIN (muscle ache at site of injection), INJECTION SITE SWELLING (L arm, site of injection swollen) and INJECTION SITE ERYTHEMA (Red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication was not provided.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: pain in arm but nothing else; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (pain in arm but nothing else) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     Concomitant products included AMOXICILLIN for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in arm but nothing else). The patient was treated with PARACETAMOL (TYLENOL) for Pain in arm, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (pain in arm but nothing else) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Injection site pain, Neck pain, Palpitations, Pulmonary pain
Clinical narrative: blurred vision; pain radiating in her neck for 24 hours; Felt foggy and had to lay down for 24 hours; injection site pain in her left arm; sharp pain in her lungs; her heart started racing; This spontaneous case was reported by a consumer and describes the occurrence of PULMONARY PAIN (sharp pain in her lungs), PALPITATIONS (her heart started racing), VISION BLURRED (blurred vision), NECK PAIN (pain radiating in her neck for 24 hours) and FEELING ABNORMAL (Felt foggy and had to lay down for 24 hours) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced PULMONARY PAIN (sharp pain in her lungs), PALPITATIONS (her heart started racing), NECK PAIN (pain radiating in her neck for 24 hours), FEELING ABNORMAL (Felt foggy and had to lay down for 24 hours) and INJECTION SITE PAIN (injection site pain in her left arm). On 09-Mar-2021, the patient experienced VISION BLURRED (blurred vision). On 07-Mar-2021, PULMONARY PAIN (sharp pain in her lungs) and PALPITATIONS (her heart started racing) had resolved. On 08-Mar-2021, NECK PAIN (pain radiating in her neck for 24 hours), FEELING ABNORMAL (Felt foggy and had to lay down for 24 hours) and INJECTION SITE PAIN (injection site pain in her left arm) had resolved. On 09-Mar-2021, VISION BLURRED (blurred vision) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided. Treatment medication was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: blurred vision; pain radiating in her neck for 24 hours; Felt foggy and had to lay down for 24 hours; injection site pain in her left arm; sharp pain in her lungs; her heart started racing; This spontaneous case was reported by a consumer and describes the occurrence of PULMONARY PAIN (sharp pain in her lungs), PALPITATIONS (her heart started racing), VISION BLURRED (blurred vision), NECK PAIN (pain radiating in her neck for 24 hours) and FEELING ABNORMAL (Felt foggy and had to lay down for 24 hours) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced PULMONARY PAIN (sharp pain in her lungs), PALPITATIONS (her heart started racing), NECK PAIN (pain radiating in her neck for 24 hours), FEELING ABNORMAL (Felt foggy and had to lay down for 24 hours) and INJECTION SITE PAIN (injection site pain in her left arm). On 09-Mar-2021, the patient experienced VISION BLURRED (blurred vision). On 07-Mar-2021, PULMONARY PAIN (sharp pain in her lungs) and PALPITATIONS (her heart started racing) had resolved. On 08-Mar-2021, NECK PAIN (pain radiating in her neck for 24 hours), FEELING ABNORMAL (Felt foggy and had to lay down for 24 hours) and INJECTION SITE PAIN (injection site pain in her left arm) had resolved. On 09-Mar-2021, VISION BLURRED (blurred vision) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided. Treatment medication was not provided.
Age: 16.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Vaccinated at age of 16; A Spontaneous report was received from a physician concerning a 16-year old patient, who received Moderna's COVID-19 vaccine (mRNA-1273).  The patient's medical history was not reported. Concomitant Medications were not listed.  On 12 Mar 2021, prior to the onset of events the patient received first dose of their two planned doses of mRNA-1273 (Batch N0: unknown) intramuscularly for prophylaxis of covid 19 infection.  The patient was received the first dose of Moderna COVID-19 vaccine at age of 16.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of event was recovered or resolved on 12 Mar 2021.; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age (16 year old) for mRNA-1273 (lot number unknown) with no associated AEs reported.
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus
Clinical narrative: A little bit itching at the injection site, it comes and goes; This spontaneous case was reported by a consumer and describes the occurrence of   in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.            No concomitant medications were provided.  No treatment details were provided.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Inflammation, Injection site inflammation, Vaccination site induration, Vaccination site pruritus
Clinical narrative: mRNA-1273 (lot/batch: 010A21A) via unknown route for prophylaxis of COVID-19 infection.  On 3 Mar 2021, the patient experienced itchiness, sensitivity at the injection site, little bit inflamed, like a lump, hard, little ring of redness, had 2 and a half inches round. Treatment details included tylenol.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Headache, Injection site pain, Injection site rash, Injection site swelling
Clinical narrative: Temperature was up a couple of degrees; rash at the injection site.The rash is approximately 2" X 3" in size and is not raised or bumpy.; Left arm is also swelling; sore throat; Stuffy nose; Feverish; feeling "achy"; Headache; Tenderness in her left arm; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (Stuffy nose), BODY TEMPERATURE INCREASED (Temperature was up a couple of degrees), PYREXIA (Feverish) and MYALGIA (feeling "achy") in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: FLU VACCINE VII. Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced INJECTION SITE PAIN (Tenderness in her left arm). On 10-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (Stuffy nose), PYREXIA (Feverish), MYALGIA (feeling "achy") and HEADACHE (Headache). On 12-Mar-2021, the patient experienced BODY TEMPERATURE INCREASED (Temperature was up a couple of degrees), INJECTION SITE RASH (rash at the injection site.The rash is approximately 2" X 3" in size and is not raised or bumpy.) and INJECTION SITE SWELLING (Left arm is also swelling). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date at an unspecified dose and frequency. On 05-Mar-2021, INJECTION SITE PAIN (Tenderness in her left arm) had resolved. At the time of the report, OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (Stuffy nose), BODY TEMPERATURE INCREASED (Temperature was up a couple of degrees), PYREXIA (Feverish), MYALGIA (feeling "achy"), HEADACHE (Headache), INJECTION SITE RASH (rash at the injection site.The rash is approximately 2" X 3" in size and is not raised or bumpy.) and INJECTION SITE SWELLING (Left arm is also swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient increased fluid intake.   Most recent FOLLOW-UP information incorporated above includes: On 30-Mar-2021: NNI
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nasal congestion, Oropharyngeal pain, Pyrexia
Clinical narrative: Temperature was up a couple of degrees; rash at the injection site.The rash is approximately 2" X 3" in size and is not raised or bumpy.; Left arm is also swelling; sore throat; Stuffy nose; Feverish; feeling "achy"; Headache; Tenderness in her left arm; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (Stuffy nose), BODY TEMPERATURE INCREASED (Temperature was up a couple of degrees), PYREXIA (Feverish) and MYALGIA (feeling "achy") in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: FLU VACCINE VII. Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced INJECTION SITE PAIN (Tenderness in her left arm). On 10-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (Stuffy nose), PYREXIA (Feverish), MYALGIA (feeling "achy") and HEADACHE (Headache). On 12-Mar-2021, the patient experienced BODY TEMPERATURE INCREASED (Temperature was up a couple of degrees), INJECTION SITE RASH (rash at the injection site.The rash is approximately 2" X 3" in size and is not raised or bumpy.) and INJECTION SITE SWELLING (Left arm is also swelling). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date at an unspecified dose and frequency. On 05-Mar-2021, INJECTION SITE PAIN (Tenderness in her left arm) had resolved. At the time of the report, OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (Stuffy nose), BODY TEMPERATURE INCREASED (Temperature was up a couple of degrees), PYREXIA (Feverish), MYALGIA (feeling "achy"), HEADACHE (Headache), INJECTION SITE RASH (rash at the injection site.The rash is approximately 2" X 3" in size and is not raised or bumpy.) and INJECTION SITE SWELLING (Left arm is also swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient increased fluid intake.   Most recent FOLLOW-UP information incorporated above includes: On 30-Mar-2021: NNI
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Asthenia, Dizziness, Magnetic resonance imaging
Clinical narrative: Anxiety; weakness; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness), DIZZINESS (Dizziness) and ANXIETY (Anxiety) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 012N20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No recorded medical history). Concomitant products included PROPRANOLOL, SIMVASTATIN and VITAMINS NOS for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Jan-2021, the patient experienced ASTHENIA (weakness) and DIZZINESS (Dizziness). On an unknown date, the patient experienced ANXIETY (Anxiety). At the time of the report, ASTHENIA (weakness) and DIZZINESS (Dizziness) had not resolved and ANXIETY (Anxiety) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Magnetic resonance imaging: inconclusive (Inconclusive) They had an MRI on the brain and neck..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Significant followup added to include AE contact info, outcome of the events and lab test. On 15-Jul-2021: Significant Follow-up added-New event "Anxiety" added, new reporter details added.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Myalgia, Nausea
Clinical narrative: nausea; aches and pains; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea) and MYALGIA (aches and pains) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced NAUSEA (nausea) and MYALGIA (aches and pains). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 11-Mar-2021, NAUSEA (nausea) had resolved. On 12-Mar-2021, MYALGIA (aches and pains) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, Heart rate: increased (High) heart racing/chest felt like it was going to explode..         No concomitant medications were reported.   This case was linked to MOD-2021-058094 (Patient Link).
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Right arm swollen; Right arm very painful; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (Right arm swollen) and INJECTION SITE PAIN (Right arm very painful) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced INJECTION SITE SWELLING (Right arm swollen) and INJECTION SITE PAIN (Right arm very painful). At the time of the report, INJECTION SITE SWELLING (Right arm swollen) and INJECTION SITE PAIN (Right arm very painful) had resolved.            Treatment medication was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Pain in extremity, Palpitations
Clinical narrative: Rapid heart palpitations; Headache; Dizziness; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), PAIN IN EXTREMITY (Sore arm), PALPITATIONS (Rapid heart palpitations) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced DIZZINESS (Dizziness), PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache). On 12-Mar-2021, the patient experienced PALPITATIONS (Rapid heart palpitations). On 12-Mar-2021, DIZZINESS (Dizziness) and HEADACHE (Headache) had not resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm) had not resolved and PALPITATIONS (Rapid heart palpitations) outcome was unknown.            Treatment medication was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Incorrect route of product administration
Clinical narrative: Vaccine was administered to a patient subcutaneously and not intramuscularly; A spontaneous report was received from a pharmacist concerning a patient, of an unknown age and gender, who received Moderna's COVID-19 vaccine (mRNA-1273) and the vaccine was administered to the patient subcutaneously and not intramuscularly.  The patient's medical history and concomitant medications were not provided by the reporter.  On 11 Mar 2021, the patient received their planned doses of mRNA-1273 (Lot number: unknown) subcutaneously for prophylaxis of COVID-19 infection.  The event was categorized as a medication error and the anatomical location of vaccine administration was not provided.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not provided.  The outcome of event, vaccine administered subcutaneously and not intramuscularly, was considered resolved on 11 Mar 2021.; Reporter's Comments: This report refers to a case of incorrect route of product administration for mRNA-1273 (lot # unknown) with no associated AEs reported.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Stress, Vaccination site pain
Clinical narrative: Lot of pressure; Headache; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of STRESS (Lot of pressure), VACCINATION SITE PAIN (Pain at injection site) and HEADACHE (Headache) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site). On 10-Mar-2021, the patient experienced HEADACHE (Headache). On 12-Mar-2021, the patient experienced STRESS (Lot of pressure). At the time of the report, STRESS (Lot of pressure) and VACCINATION SITE PAIN (Pain at injection site) outcome was unknown and HEADACHE (Headache) had not resolved.            No Concomitant medications were provided.  No treatment details were provided.    Reporter did not allow further contact
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash macular
Clinical narrative: Raised bumps on both arms; A patch on her right knee; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Raised bumps on both arms) and RASH (A patch on her right knee) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced RASH MACULAR (Raised bumps on both arms) and RASH (A patch on her right knee). At the time of the report, RASH MACULAR (Raised bumps on both arms) and RASH (A patch on her right knee) outcome was unknown. Not Related      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling, Musculoskeletal stiffness, Pain
Clinical narrative: sore; stiff arm; red around the site of injection; swollen around the site of injection; This spontaneous case was reported by a patient and describes the occurrence of PAIN (sore), MUSCULOSKELETAL STIFFNESS (stiff arm), INJECTION SITE ERYTHEMA (red around the site of injection) and INJECTION SITE SWELLING (swollen around the site of injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (sore), MUSCULOSKELETAL STIFFNESS (stiff arm), INJECTION SITE ERYTHEMA (red around the site of injection) and INJECTION SITE SWELLING (swollen around the site of injection). At the time of the report, PAIN (sore), MUSCULOSKELETAL STIFFNESS (stiff arm), INJECTION SITE ERYTHEMA (red around the site of injection) and INJECTION SITE SWELLING (swollen around the site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant product use was not provided by the reporter.   Treatment information was not provided.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site rash, Pruritus, Rash, Skin discolouration
Clinical narrative: It looks like my arm was burnt because it is all black; Itching all over the arm; Rash started to get bigger and covered whole arm; Little red spot at injection site; rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOLOURATION (It looks like my arm was burnt because it is all black), PRURITUS (Itching all over the arm), RASH (Rash started to get bigger and covered whole arm), INJECTION SITE ERYTHEMA (Little red spot at injection site) and INJECTION SITE RASH (rash at injection site) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20H) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (Little red spot at injection site) and INJECTION SITE RASH (rash at injection site). On 22-Feb-2021, the patient experienced PRURITUS (Itching all over the arm) and RASH (Rash started to get bigger and covered whole arm). On an unknown date, the patient experienced SKIN DISCOLOURATION (It looks like my arm was burnt because it is all black). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at a dose of UNK dosage form. At the time of the report, SKIN DISCOLOURATION (It looks like my arm was burnt because it is all black), PRURITUS (Itching all over the arm), RASH (Rash started to get bigger and covered whole arm), INJECTION SITE ERYTHEMA (Little red spot at injection site) and INJECTION SITE RASH (rash at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient reported that after receiving vaccine, on 15-Feb-2021 the patient had rash, little red spot on arm at injection site. It started to get bigger on 22-Feb-2021 and it covered whole arm. She also said that it was itching all over the arm. She said that she was given steroids and diphenhydramine (Benadryl) by her HCP. She said it was better now but it was looking like her arm was burnt because it was all black. She mentioned that her doctor asked her to not to get second shot. According to the patient, she was not taking concomitant medication.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Hypertension, Pyrexia
Clinical narrative: A week after receiving the vaccine he went to the hospital with high blood pressure; Was light headed; Chills; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (A week after receiving the vaccine he went to the hospital with high blood pressure), DIZZINESS (Was light headed), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (A week after receiving the vaccine he went to the hospital with high blood pressure), DIZZINESS (Was light headed), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, HYPERTENSION (A week after receiving the vaccine he went to the hospital with high blood pressure), DIZZINESS (Was light headed), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products included high blood pressure medications.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Dizziness, Headache, Myalgia
Clinical narrative: Weakness; Dizziness; Feet have been tingling; Chills; Body aches; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), DIZZINESS (Dizziness), PARAESTHESIA (Feet have been tingling), CHILLS (Chills) and MYALGIA (Body aches) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced ASTHENIA (Weakness), DIZZINESS (Dizziness), PARAESTHESIA (Feet have been tingling), CHILLS (Chills), MYALGIA (Body aches) and HEADACHE (Headaches). At the time of the report, ASTHENIA (Weakness), DIZZINESS (Dizziness), PARAESTHESIA (Feet have been tingling), CHILLS (Chills), MYALGIA (Body aches) and HEADACHE (Headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment details were provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Weakness; Dizziness; Feet have been tingling; Chills; Body aches; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), DIZZINESS (Dizziness), PARAESTHESIA (Feet have been tingling), CHILLS (Chills) and MYALGIA (Body aches) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced ASTHENIA (Weakness), DIZZINESS (Dizziness), PARAESTHESIA (Feet have been tingling), CHILLS (Chills), MYALGIA (Body aches) and HEADACHE (Headaches). At the time of the report, ASTHENIA (Weakness), DIZZINESS (Dizziness), PARAESTHESIA (Feet have been tingling), CHILLS (Chills), MYALGIA (Body aches) and HEADACHE (Headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment details were provided.